Opinion Piece Outlines 5 Steps To Help Identify, Treat Patients With MDR-TB
Scientific American: Five Interventions for Treating Multidrug-Resistant TB
Ifeanyi Nsofor, medical doctor, CEO of EpiAFRIC, and director of policy and advocacy at Nigeria Health Watch
“…The U.S. Food and Drug Administration has approved an oral combination for the treatment of multidrug-resistant tuberculosis (MDR-TB). … This novel drug combination could be a game changer in managing tuberculosis and lead to increased survival of individuals infected with TB. … It could take a while for the new FDA-approved drug combination to be widely available, especially in resource-poor settings. In the meantime, governments working with communities, health workers, the private sector, and civil society organizations should intensify efforts to prevent tuberculosis, increase adherence to currently available treatments, and deploy appropriate technologies in tuberculosis programming…” (10/2).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.